uk
uk · page 14
- CBD Market
CBD-brand MYO launches in Boots across the UK
MYO will be available in 838 Boots stores across the country.
- Policy & Regulation
New report lays out cannabis social equity principles for UK
The new report for the UK’s legal cannabis industry has been published by the national centre of expertise on drugs and drugs law in the UK, Release.
- Medical
Agreement aims to approve first cannabis vaporiser for European patients
A collaboration will see studies undertaken to prove the efficacy and safety of the device.
- Companies
Productive start to 2022 for Apollon Formularies
The company has secured new agreements, confirmed the renewal of licenses and has appointed a new non-executive director.
- Policy & Regulation
It is time for London to pilot a legal cannabis industry
Londoners have had enough of the violence linked to the illicit drugs trade in the city.
- Cultivation
Cannabis cultivation agreements will work with Jamaican farmers
UK-based Apollon Formularies is aiming to increase the supply of medical cannabis through its new agreements.
- CBD Market
Chill Brands appoints Michael Sandore as chief commercial officer
Sandore will lead the company’s sales and marketing group.
- Policy & Regulation
London to trial new diversion pilot for cannabis possession
The pilot will see young people who have been caught with small amounts of cannabis diverted away from the criminal justice system and into support services.
- CBD Market
Voyager Life acquires Cannafull and Ascend Skincare
Voyager has acquired the companies after parent company Cannafull Ltd recently went into liquidation.
- CBD Market
Chill Brands partners with US soccer league to offer CBD products
Chill Brands is partnering with the league to offer products to member teams.
- CBD Market
Industry responds to new ACMD CBD product advice
Cannabis industry members have responded to the new ACMD issued advice for consumer CBD products.
- Medical
Glass Pharms: initiating domestic supply of medical cannabis in the UK
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
